CCL2 and neoplasm: Our computational analysis suggests that HPV − tumor cells have a stronger reliance on IL6/IL6R and CCL2/CCR2 signaling within the tumor microenvironment (TME) to evade NK cell immune attack, in contrast to HPV + tumors.